David M. Mott, Director at Epizyme, Inc. (EPZM), sold 52,472 shares at $12.85 ($674K) on 2019-06-26, disclosed to the SEC on 2019-06-26.
Open-market sale of $674k EPZM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ARDX | BUY | 2025-06-11 | $738K | — | Filing → |
| ARDX | BUY | 2025-05-19 | $329K | — | Filing → |
| ARDX | BUY | 2025-05-05 | $3.2M | — | Filing → |